Rosiglitazone (CAS 122320-73-4) Market, Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: R87FBE7AC894EN
Market Monitor Global

Abstracts

Rosiglitazone (CAS 122320-73-4), C18H19N3O3S, the formula weight is 357.43, and its form is powder.

This report contains market size and forecasts of Rosiglitazone (CAS 122320-73-4) in global, including the following market information:

Global Rosiglitazone (CAS 122320-73-4) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Rosiglitazone (CAS 122320-73-4) Market Sales, 2017-2022, 2023-2028, (Kg)

Global top five Rosiglitazone (CAS 122320-73-4) companies in 2021 (%)

The global Rosiglitazone (CAS 122320-73-4) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Rosiglitazone Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rosiglitazone (CAS 122320-73-4) include Hengrui Pharma, GSK, Taiji Group, Shengjitang Pharma, Huanghe Pharma, Wanma Pharma, Jingxin Pharma and STADA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rosiglitazone (CAS 122320-73-4) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rosiglitazone (CAS 122320-73-4) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Rosiglitazone (CAS 122320-73-4) Market Segment Percentages, by Type, 2021 (%)

• Rosiglitazone Tablets
• Rosiglitazone Maleate Tablets
• Rosiglitazone Hydrochloride Tablets
• Others

Global Rosiglitazone (CAS 122320-73-4) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Rosiglitazone (CAS 122320-73-4) Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Rosiglitazone (CAS 122320-73-4) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Rosiglitazone (CAS 122320-73-4) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rosiglitazone (CAS 122320-73-4) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Rosiglitazone (CAS 122320-73-4) revenues share in global market, 2021 (%)

Key companies Rosiglitazone (CAS 122320-73-4) sales in global market, 2017-2022 (Estimated), (Kg)

Key companies Rosiglitazone (CAS 122320-73-4) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Hengrui Pharma
• GSK
• Taiji Group
• Shengjitang Pharma
• Huanghe Pharma
• Wanma Pharma
• Jingxin Pharma
• STADA

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rosiglitazone (CAS 122320-73-4) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rosiglitazone (CAS 122320-73-4) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ROSIGLITAZONE (CAS 122320-73-4) OVERALL MARKET SIZE

2.1 Global Rosiglitazone (CAS 122320-73-4) Market Size: 2021 VS 2028
2.2 Global Rosiglitazone (CAS 122320-73-4) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Rosiglitazone (CAS 122320-73-4) Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Rosiglitazone (CAS 122320-73-4) Players in Global Market
3.2 Top Global Rosiglitazone (CAS 122320-73-4) Companies Ranked by Revenue
3.3 Global Rosiglitazone (CAS 122320-73-4) Revenue by Companies
3.4 Global Rosiglitazone (CAS 122320-73-4) Sales by Companies
3.5 Global Rosiglitazone (CAS 122320-73-4) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Rosiglitazone (CAS 122320-73-4) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Rosiglitazone (CAS 122320-73-4) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rosiglitazone (CAS 122320-73-4) Players in Global Market
  3.8.1 List of Global Tier 1 Rosiglitazone (CAS 122320-73-4) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Rosiglitazone (CAS 122320-73-4) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Rosiglitazone (CAS 122320-73-4) Market Size Markets, 2021 & 2028
  4.1.2 Rosiglitazone Tablets
  4.1.3 Rosiglitazone Maleate Tablets
  4.1.4 Rosiglitazone Hydrochloride Tablets
  4.1.5 Others
4.2 By Type - Global Rosiglitazone (CAS 122320-73-4) Revenue & Forecasts
  4.2.1 By Type - Global Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2022
  4.2.2 By Type - Global Rosiglitazone (CAS 122320-73-4) Revenue, 2023-2028
  4.2.3 By Type - Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
4.3 By Type - Global Rosiglitazone (CAS 122320-73-4) Sales & Forecasts
  4.3.1 By Type - Global Rosiglitazone (CAS 122320-73-4) Sales, 2017-2022
  4.3.2 By Type - Global Rosiglitazone (CAS 122320-73-4) Sales, 2023-2028
  4.3.3 By Type - Global Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
4.4 By Type - Global Rosiglitazone (CAS 122320-73-4) Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rosiglitazone (CAS 122320-73-4) Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Rosiglitazone (CAS 122320-73-4) Revenue & Forecasts
  5.2.1 By Application - Global Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2022
  5.2.2 By Application - Global Rosiglitazone (CAS 122320-73-4) Revenue, 2023-2028
  5.2.3 By Application - Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
5.3 By Application - Global Rosiglitazone (CAS 122320-73-4) Sales & Forecasts
  5.3.1 By Application - Global Rosiglitazone (CAS 122320-73-4) Sales, 2017-2022
  5.3.2 By Application - Global Rosiglitazone (CAS 122320-73-4) Sales, 2023-2028
  5.3.3 By Application - Global Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
5.4 By Application - Global Rosiglitazone (CAS 122320-73-4) Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rosiglitazone (CAS 122320-73-4) Market Size, 2021 & 2028
6.2 By Region - Global Rosiglitazone (CAS 122320-73-4) Revenue & Forecasts
  6.2.1 By Region - Global Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2022
  6.2.2 By Region - Global Rosiglitazone (CAS 122320-73-4) Revenue, 2023-2028
  6.2.3 By Region - Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
6.3 By Region - Global Rosiglitazone (CAS 122320-73-4) Sales & Forecasts
  6.3.1 By Region - Global Rosiglitazone (CAS 122320-73-4) Sales, 2017-2022
  6.3.2 By Region - Global Rosiglitazone (CAS 122320-73-4) Sales, 2023-2028
  6.3.3 By Region - Global Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2028
  6.4.2 By Country - North America Rosiglitazone (CAS 122320-73-4) Sales, 2017-2028
  6.4.3 US Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.4.4 Canada Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.4.5 Mexico Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2028
  6.5.2 By Country - Europe Rosiglitazone (CAS 122320-73-4) Sales, 2017-2028
  6.5.3 Germany Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.5.4 France Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.5.5 U.K. Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.5.6 Italy Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.5.7 Russia Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.5.8 Nordic Countries Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.5.9 Benelux Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2028
  6.6.2 By Region - Asia Rosiglitazone (CAS 122320-73-4) Sales, 2017-2028
  6.6.3 China Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.6.4 Japan Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.6.5 South Korea Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.6.6 Southeast Asia Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.6.7 India Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2028
  6.7.2 By Country - South America Rosiglitazone (CAS 122320-73-4) Sales, 2017-2028
  6.7.3 Brazil Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.7.4 Argentina Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Rosiglitazone (CAS 122320-73-4) Sales, 2017-2028
  6.8.3 Turkey Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.8.4 Israel Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.8.5 Saudi Arabia Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028
  6.8.6 UAE Rosiglitazone (CAS 122320-73-4) Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Hengrui Pharma
  7.1.1 Hengrui Pharma Corporate Summary
  7.1.2 Hengrui Pharma Business Overview
  7.1.3 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Major Product Offerings
  7.1.4 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Sales and Revenue in Global (2017-2022)
  7.1.5 Hengrui Pharma Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Rosiglitazone (CAS 122320-73-4) Major Product Offerings
  7.2.4 GSK Rosiglitazone (CAS 122320-73-4) Sales and Revenue in Global (2017-2022)
  7.2.5 GSK Key News
7.3 Taiji Group
  7.3.1 Taiji Group Corporate Summary
  7.3.2 Taiji Group Business Overview
  7.3.3 Taiji Group Rosiglitazone (CAS 122320-73-4) Major Product Offerings
  7.3.4 Taiji Group Rosiglitazone (CAS 122320-73-4) Sales and Revenue in Global (2017-2022)
  7.3.5 Taiji Group Key News
7.4 Shengjitang Pharma
  7.4.1 Shengjitang Pharma Corporate Summary
  7.4.2 Shengjitang Pharma Business Overview
  7.4.3 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Major Product Offerings
  7.4.4 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Sales and Revenue in Global (2017-2022)
  7.4.5 Shengjitang Pharma Key News
7.5 Huanghe Pharma
  7.5.1 Huanghe Pharma Corporate Summary
  7.5.2 Huanghe Pharma Business Overview
  7.5.3 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Major Product Offerings
  7.5.4 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Sales and Revenue in Global (2017-2022)
  7.5.5 Huanghe Pharma Key News
7.6 Wanma Pharma
  7.6.1 Wanma Pharma Corporate Summary
  7.6.2 Wanma Pharma Business Overview
  7.6.3 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Major Product Offerings
  7.6.4 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Sales and Revenue in Global (2017-2022)
  7.6.5 Wanma Pharma Key News
7.7 Jingxin Pharma
  7.7.1 Jingxin Pharma Corporate Summary
  7.7.2 Jingxin Pharma Business Overview
  7.7.3 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Major Product Offerings
  7.7.4 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Sales and Revenue in Global (2017-2022)
  7.7.5 Jingxin Pharma Key News
7.8 STADA
  7.8.1 STADA Corporate Summary
  7.8.2 STADA Business Overview
  7.8.3 STADA Rosiglitazone (CAS 122320-73-4) Major Product Offerings
  7.8.4 STADA Rosiglitazone (CAS 122320-73-4) Sales and Revenue in Global (2017-2022)
  7.8.5 STADA Key News

8 GLOBAL ROSIGLITAZONE (CAS 122320-73-4) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Rosiglitazone (CAS 122320-73-4) Production Capacity, 2017-2028
8.2 Rosiglitazone (CAS 122320-73-4) Production Capacity of Key Manufacturers in Global Market
8.3 Global Rosiglitazone (CAS 122320-73-4) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ROSIGLITAZONE (CAS 122320-73-4) SUPPLY CHAIN ANALYSIS

10.1 Rosiglitazone (CAS 122320-73-4) Industry Value Chain
10.2 Rosiglitazone (CAS 122320-73-4) Upstream Market
10.3 Rosiglitazone (CAS 122320-73-4) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Rosiglitazone (CAS 122320-73-4) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Rosiglitazone (CAS 122320-73-4) in Global Market
Table 2. Top Rosiglitazone (CAS 122320-73-4) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Rosiglitazone (CAS 122320-73-4) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Companies, 2017-2022
Table 5. Global Rosiglitazone (CAS 122320-73-4) Sales by Companies, (Kg), 2017-2022
Table 6. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Rosiglitazone (CAS 122320-73-4) Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Rosiglitazone (CAS 122320-73-4) Product Type
Table 9. List of Global Tier 1 Rosiglitazone (CAS 122320-73-4) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rosiglitazone (CAS 122320-73-4) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Rosiglitazone (CAS 122320-73-4) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Rosiglitazone (CAS 122320-73-4) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Rosiglitazone (CAS 122320-73-4) Sales (Kg), 2017-2022
Table 15. By Type - Global Rosiglitazone (CAS 122320-73-4) Sales (Kg), 2023-2028
Table 16. By Application – Global Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Rosiglitazone (CAS 122320-73-4) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Rosiglitazone (CAS 122320-73-4) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Rosiglitazone (CAS 122320-73-4) Sales (Kg), 2017-2022
Table 20. By Application - Global Rosiglitazone (CAS 122320-73-4) Sales (Kg), 2023-2028
Table 21. By Region – Global Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Rosiglitazone (CAS 122320-73-4) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Rosiglitazone (CAS 122320-73-4) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Rosiglitazone (CAS 122320-73-4) Sales (Kg), 2017-2022
Table 25. By Region - Global Rosiglitazone (CAS 122320-73-4) Sales (Kg), 2023-2028
Table 26. By Country - North America Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2017-2022
Table 29. By Country - North America Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2023-2028
Table 30. By Country - Europe Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2017-2022
Table 33. By Country - Europe Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2023-2028
Table 34. By Region - Asia Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2017-2022
Table 37. By Region - Asia Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2023-2028
Table 38. By Country - South America Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2017-2022
Table 41. By Country - South America Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Rosiglitazone (CAS 122320-73-4) Sales, (Kg), 2023-2028
Table 46. Hengrui Pharma Corporate Summary
Table 47. Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Product Offerings
Table 48. Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Rosiglitazone (CAS 122320-73-4) Product Offerings
Table 51. GSK Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Taiji Group Corporate Summary
Table 53. Taiji Group Rosiglitazone (CAS 122320-73-4) Product Offerings
Table 54. Taiji Group Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Shengjitang Pharma Corporate Summary
Table 56. Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Product Offerings
Table 57. Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Huanghe Pharma Corporate Summary
Table 59. Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Product Offerings
Table 60. Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Wanma Pharma Corporate Summary
Table 62. Wanma Pharma Rosiglitazone (CAS 122320-73-4) Product Offerings
Table 63. Wanma Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Jingxin Pharma Corporate Summary
Table 65. Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Product Offerings
Table 66. Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. STADA Corporate Summary
Table 68. STADA Rosiglitazone (CAS 122320-73-4) Product Offerings
Table 69. STADA Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Rosiglitazone (CAS 122320-73-4) Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 71. Global Rosiglitazone (CAS 122320-73-4) Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Rosiglitazone (CAS 122320-73-4) Production by Region, 2017-2022 (Kg)
Table 73. Global Rosiglitazone (CAS 122320-73-4) Production by Region, 2023-2028 (Kg)
Table 74. Rosiglitazone (CAS 122320-73-4) Market Opportunities & Trends in Global Market
Table 75. Rosiglitazone (CAS 122320-73-4) Market Drivers in Global Market
Table 76. Rosiglitazone (CAS 122320-73-4) Market Restraints in Global Market
Table 77. Rosiglitazone (CAS 122320-73-4) Raw Materials
Table 78. Rosiglitazone (CAS 122320-73-4) Raw Materials Suppliers in Global Market
Table 79. Typical Rosiglitazone (CAS 122320-73-4) Downstream
Table 80. Rosiglitazone (CAS 122320-73-4) Downstream Clients in Global Market
Table 81. Rosiglitazone (CAS 122320-73-4) Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Rosiglitazone (CAS 122320-73-4) Segment by Type
Figure 2. Rosiglitazone (CAS 122320-73-4) Segment by Application
Figure 3. Global Rosiglitazone (CAS 122320-73-4) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rosiglitazone (CAS 122320-73-4) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rosiglitazone (CAS 122320-73-4) Revenue, 2017-2028 (US$, Mn)
Figure 7. Rosiglitazone (CAS 122320-73-4) Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Rosiglitazone (CAS 122320-73-4) Revenue in 2021
Figure 9. By Type - Global Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
Figure 10. By Type - Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Rosiglitazone (CAS 122320-73-4) Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
Figure 13. By Application - Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Rosiglitazone (CAS 122320-73-4) Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
Figure 16. By Region - Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
Figure 19. US Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
Figure 24. Germany Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 25. France Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
Figure 33. China Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 37. India Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
Figure 40. Brazil Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Rosiglitazone (CAS 122320-73-4) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Rosiglitazone (CAS 122320-73-4) Sales Market Share, 2017-2028
Figure 44. Turkey Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Rosiglitazone (CAS 122320-73-4) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Rosiglitazone (CAS 122320-73-4) Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Rosiglitazone (CAS 122320-73-4) by Region, 2021 VS 2028
Figure 50. Rosiglitazone (CAS 122320-73-4) Industry Value Chain
Figure 51. Marketing Channels